A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF
TNF can be inhibited by small molecules that stabilize the TNF trimer in an asymmetric conformation. Here, the authors develop a monoclonal antibody that selectively binds this inactive form of TNF, enabling both target engagement assessment and structural characterization of TNF binding to TNF rece...
Guardado en:
Autores principales: | Daniel J. Lightwood, Rebecca J. Munro, John Porter, David McMillan, Bruce Carrington, Alison Turner, Anthony Scott-Tucker, Elizabeth S. Hickford, Antje Schmidt, David Fox, Alison Maloney, Tom Ceska, Tim Bourne, James O’Connell, Alastair D. G. Lawson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a700e6f6d0e341fa8bbbdf0203d53866 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF
por: David McMillan, et al.
Publicado: (2021) -
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
por: James O’Connell, et al.
Publicado: (2019) -
Anion stabilised hypercloso-hexaalane Al6H6
por: Simon J. Bonyhady, et al.
Publicado: (2018) -
Silk micrococoons for protein stabilisation and molecular encapsulation
por: Ulyana Shimanovich, et al.
Publicado: (2017) -
Humanization and characterization of an anti-human TNF-α murine monoclonal antibody.
por: Wei-Chun Chiu, et al.
Publicado: (2011)